Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Another Financing - Seriously?
View:
Post by consultant99 on Oct 03, 2022 3:58pm

Another Financing - Seriously?

Giving away more shares at 0.25 plus warrants.

Exactly how does this instill confidence for new investors that the company is on the cusp of getting BTD and a positive vaccine animal trial? 

Every time the stock starts to move higher - whack! We were over 0.36 when the first round of the latest financing started. To go back-to-back is just cruel.and now the share price is sitting at 0.24/share. 

If you value the warrants at roughly half the share price I suppose we could see the price drop to 0.17 if existing shareholders are liquidating to participate.
I don't think that will happen or at least I hope not.

I wonder if insiders will participate in the second financing as well...
Comment by Johnandrose22 on Oct 03, 2022 5:05pm
Your post is painfully realistic. I will be keenly observant of whether the clinical timelines in the next corporate update will have changed, as they have throughout this year. I am hoping...pleading...they do not...but..
Comment by FGPstock on Oct 03, 2022 5:41pm
Consultant, I agree... When a few of us said a small PP was needed, we were bashed for that opinion, now everyone thinks this is a great idea. While I expected a PP, if BTD is a few months away, I don't see the need for $2.5MM or $5MM, also, why extend .50 warrants to 2024 unless TLT doesn't expect the price to be ALOT higher like the rest of us do. Now there are 10MM more shares at .25 ...more  
Comment by Rumpl3StiltSkin on Oct 03, 2022 8:05pm
Yawn, the bashers are back. So FGP you were for the PP before you were against it? Lol, It always made sense to do a small PP IF the money was going to get tight before Approval. I was Optimistic they would do it later. I was wrong. Perhaps they are being conservative and thought it better to have the funds in place now so SP can take it's natural course when news on Covid Vax, GLP, Multiple ...more  
Comment by FGPstock on Oct 03, 2022 11:01pm
Rumpy, I was for a small PP, if needed until they got to BTD, then they could raise at much higher levels, not dillute the stock as much, etc. This is just common sense. I would love to not dillute at all, but why raise 5 million at .25c if BTD is right around the corner. You can say I am a basher, but I am actually just trying to keep the share structure as tight as possible. TLT is the ones who ...more  
Comment by robertshaw on Oct 04, 2022 7:28am
Completely agree you. As I hold over 600k, from past 8 years , and was also deemed as a basher.
Comment by Lesalpes29 on Oct 04, 2022 8:24am
When we can expect a better SP in the coming months it's difficult to see why an other PP now at this price (but easy to imagine wolves just behind the doors!). BTD, AA and vaccine results are suppose to be positive no? Vaccine results with money upfront no! Anyway, nothing we can do... and on the positive side, money will not be a problem in the coming months.
Comment by Oilminerdeluxe on Oct 04, 2022 8:41am
Maybe action time for real in the coming weeks then. Hope so.
Comment by Legit62 on Oct 04, 2022 9:49am
My feeling on the financing is they needed working capital to start new trials,the number of shares doled out not that crazy, who cares if insiders got more, not a bad thing even though the SP is low now, and i also believe we are in for some big news soon which will ease all the active minds out there. This is a small biotech company trying to make a name for itself, if i didnt believe in the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250